CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of GBP 373.58 million. The enterprise value is 366.04 million.

Market Cap	373.58M
Enterprise Value	366.04M

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	May 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.81M

Valuation Ratios

The trailing PE ratio is 33.81.

PE Ratio	33.81
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.26, with an EV/FCF ratio of 23.39.

EV / Earnings	33.13
EV / Sales	6.74
EV / EBITDA	22.26
EV / EBIT	26.29
EV / FCF	23.39

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.05.

Current Ratio	3.04
Quick Ratio	2.15
Debt / Equity	0.05
Debt / EBITDA	0.16
Debt / FCF	0.17
Interest Coverage	114.06

Financial Efficiency

Return on equity (ROE) is 20.78% and return on invested capital (ROIC) is 15.16%.

Return on Equity (ROE)	20.78%
Return on Assets (ROA)	12.57%
Return on Capital (ROIC)	15.16%
Revenue Per Employee	237,841
Profits Per Employee	48,465
Employee Count	228
Asset Turnover	0.78
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.96% in the last 52 weeks. The beta is 1.23, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	+13.96%
50-Day Moving Average	220.87
200-Day Moving Average	247.91
Relative Strength Index (RSI)	44.78
Average Volume (20 Days)	369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of GBP 54.23 million and earned 11.05 million in profits. Earnings per share was 0.46.

Revenue	54.23M
Gross Profit	36.33M
Operating Income	13.89M
Pretax Income	13.88M
Net Income	11.05M
EBITDA	15.53M
EBIT	13.89M
Earnings Per Share (EPS)	0.46

Full Income Statement

Balance Sheet

The company has 10.13 million in cash and 2.60 million in debt, giving a net cash position of 7.52 million.

Cash & Cash Equivalents	10.13M
Total Debt	2.60M
Net Cash	7.52M
Net Cash Per Share	n/a
Equity (Book Value)	56.49M
Book Value Per Share	2.37
Working Capital	19.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.84 million and capital expenditures -1.18 million, giving a free cash flow of 15.65 million.

Operating Cash Flow	16.84M
Capital Expenditures	-1.18M
Free Cash Flow	15.65M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 66.99%, with operating and profit margins of 25.62% and 20.38%.

Gross Margin	66.99%
Operating Margin	25.62%
Pretax Margin	25.60%
Profit Margin	20.38%
EBITDA Margin	28.65%
EBIT Margin	25.62%
FCF Margin	28.86%

Dividends & Yields

CellaVision AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-5.62%
Years of Dividend Growth	n/a
Payout Ratio	35.73%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.96%
FCF Yield	4.19%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a